Sandoz Group AG
SDZ
Rangering i aksjer
#579
Operating globally, Sandoz Group AG specializes in the development, production,... Operating globally, Sandoz Group AG specializes in the development, production, and distribution of generic medications and biosimilar products. The company's portfolio includes the creation and sale of finished dosage forms for small molecule pharmaceuticals, often supplied to other entities. Sandoz is also a significant player in the biotechnology sector, providing protein-based products such as biosimilars and offering specialized manufacturing services within this field. Furthermore, it supplies anti-infective products, including active pharmaceutical ingredients (APIs) and intermediates, with a strong emphasis on antibiotics. Established in 1886, Sandoz maintains its headquarters in Rotkreuz, Switzerland.
Aksjekurs
$95.99
Markedsverdi
$41.53B
Endring (1 dag)
0.79%
Endring (1 år)
58.61%
Land
CH
Handel Sandoz Group AG (SDZ)
Kategori
Healthcare
EPS for Sandoz Group AG (SDZ)
EPS per 2026 TTM: 0
Ifølge de siste økonomiske rapportene og aksjekursen til Sandoz Group AG er selskapets nåværende EPS (TTM) 0. Ved slutten av 2026 hadde selskapet en EPS på 0, lik EPS-en i 2026 som var 0.
EPS-historikk for Sandoz Group AG fra 2020 til 2026
EPS ved slutten av hvert år
| År | EPS | Endre |
|---|---|---|
| 2025 | $2.12 | 0.00% |
| 2024 | 0.00 | -100.00% |
| 2023 | $0.18 | -90.86% |
| 2022 | $1.97 | 2.60% |
| 2021 | $1.92 | 102.11% |
| 2020 | $0.95 | 0.00% |
EPS for lignende selskaper eller konkurrenter
| Selskap | EPS | EPS-forskjell | Land |
|---|---|---|---|
| - | - |
DE
|
|
| - | - |
DE
|
|
| - | - |
JP
|
|
| - | - |
CH
|
|
| $0.56 | - |
IN
|
